Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
-
 
WKN: A14SDD / Name: Blueprint / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Blueprint Medicines Corp Stock

Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Blueprint Medicines Corp stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Blueprint Medicines Corp in the next few years

Pros
?
M***** P*******
?
G***** c******* t* c**********
?
S********** s********
Cons
?
C******** o* t** e**********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Blueprint Medicines Corp vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Blueprint Medicines Corp - - - - - - -
Ironwood Pharmaceuticals 0.000% -1.351% 63.128% -21.081% -30.476% -73.627% -70.204%
Novocure Ltd 5.110% 16.355% 15.739% -59.768% -62.448% -84.713% -91.791%
Iovance Biotherapeutics Inc. -0.400% 5.140% -2.701% -77.202% -72.039% -70.551% -94.950%

News

Why Ford's Deal With Amazon Is Bigger Than You Think: https://www.marketbeat.com/logos/articles/med_20251118140226_why-fords-deal-with-amazon-is-bigger-than-you-thin.png
Why Ford's Deal With Amazon Is Bigger Than You Think

Ford Motor Company (NYSE: F) has made a groundbreaking move in automotive retail, announcing a partnership to sell its certified pre-owned (CPO) vehicles directly on Amazon (NASDAQ: AMZN).

This

Time to Take Notice: PEGA’s GenAI Blueprint Delivers Huge Q3 Beat: https://www.marketbeat.com/logos/articles/med_20251024150553_time-to-take-notice-pegas-genai-blueprint-delivers.jpg
Time to Take Notice: PEGA’s GenAI Blueprint Delivers Huge Q3 Beat

On a day that saw a handful of highly impressive earnings reports, tech stock Pegasystems (NASDAQ: PEGA) more than held its own. Shares blasted up by 15% on Oct. 22 as the market digested the

PEGA Surges 14%: There's Still Time to Ride This GenAI Innovator
PEGA Surges 14%: There's Still Time to Ride This GenAI Innovator

For the second quarter in a row, artificial intelligence (AI) tech stock Pegasystems (NASDAQ: PEGA) crushed expectations.

Shares soared 14% on July 22 as the company eclipsed Wall Street